13F filer · CIK 354204 ↗
Dimensional Fund Advisors LP
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$220.75B
−16% on the quarter before
Positions
3,448
113 new · 90 sold out
Top 10
9.7%
of the value
Est. gain
−$42.17B
on stocks held all quarter
Est. return
−16.7%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Dimensional Fund Advisors LP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 16% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cigna Corp New~$672.2MNew · 0.0% → 0.3%+3,539,322 shares
- Marathon Pete Corp~$245.1MAdded · 0.2% → 0.3%+4,153,879 shares
- Cvs Health Corp~$199.3MAdded · 0.3% → 0.4%+3,041,266 shares
- Conocophillips~$157.9MAdded · 0.3% → 0.3%+2,532,290 shares
- Linde Plc~$126.7MNew · 0.0% → 0.1%+812,164 shares
- Liveramp Hldgs Inc~$118.5MNew · 0.0% → 0.1%+3,066,256 shares
- Chevron Corp New~$114.7MAdded · 0.6% → 0.7%+1,054,546 shares
- Fedex Corp~$67.5MAdded · 0.2% → 0.2%+418,451 shares
- Intl Paper Co~$67.3MAdded · 0.0% → 0.1%+1,667,274 shares
- Eog Res Inc~$63.9MAdded · 0.1% → 0.1%+732,531 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Aetna Inc New~$740.1MSold out · 0.3% → 0.0%−3,648,387 shares
- Express Scripts Hldg Co~$612.3MSold out · 0.2% → 0.0%−6,444,369 shares
- Andeavor~$446.7MSold out · 0.2% → 0.0%−2,909,846 shares
- Cigna Corporation~$403.7MSold out · 0.2% → 0.0%−1,938,791 shares
- Cisco~$290.4MCut · 0.5% → 0.5%−6,701,595 shares
- Ca Inc~$251.5MSold out · 0.1% → 0.0%−5,697,564 shares
- Klx Inc~$227.1MSold out · 0.1% → 0.0%−3,617,481 shares
- Lifepoint Health Inc~$210.5MSold out · 0.1% → 0.0%−3,269,010 shares
- Wells Fargo Co New~$210.4MCut · 0.8% → 0.7%−4,565,878 shares
- Convergys Corp~$181.7MSold out · 0.1% → 0.0%−7,653,945 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +1.3% · price −30.1% | 1.2% | $2.60B | −$1.11B | ||||||||
| IntelCOM · shares −0.2% · price −0.7% | 1.1% | $2.39B | −$17.8M | ||||||||
| Pfizer IncCOM · shares −2.4% · price −1.0% | 1.0% | $2.27B | −$22.0M | ||||||||
| AT&TCOM · shares −2.0% · price −15.0% | 1.0% | $2.23B | −$393.5M | ||||||||
| Exxon Mobil CorpCOM · shares +1.4% · price −19.8% | 1.0% | $2.22B | −$539.9M | ||||||||
| MicrosoftCOM · shares +1.4% · price −11.2% | 0.99% | $2.18B | −$270.6M | ||||||||
| Jpmorgan Chase & CoCOM · shares −6.4% · price −13.5% | 0.94% | $2.07B | −$323.1M | ||||||||
| AmazonCOM · shares +2.3% · price −25.0% | 0.84% | $1.86B | −$606.5M | ||||||||
| Comcast Corp NewCLA · shares +0.6% · price −3.8% | 0.83% | $1.82B | −$72.2M | ||||||||
| Berkshire Hathaway Inc DelCLB · shares +2.3% · price −4.6% | 0.77% | $1.70B | −$81.0M | ||||||||
| Wells Fargo Co NewCOM · shares −11% · price −12.3% | 0.74% | $1.62B | −$228.5M | ||||||||
| Chevron Corp NewCOM · shares +8.1% · price −11.0% | 0.70% | $1.53B | −$176.1M | ||||||||
| Bank Amer CorpCOM · shares −7.3% · price −16.4% | 0.61% | $1.36B | −$265.5M | ||||||||
| Walmart IncCOM · shares −11% · price −0.8% | 0.52% | $1.16B | −$9.5M | ||||||||
| American TowerCOM · shares +2.2% · price +8.9% | 0.47% | $1.04B | +$82.7M | ||||||||
| Johnson & JohnsonCOM · shares −0.6% · price −6.6% | 0.46% | $1.02B | −$72.0M | ||||||||
| Verizon Communications IncCOM · shares +1.4% · price +5.3% | 0.46% | $1.01B | +$49.8M | ||||||||
| CiscoCOM · shares −23% · price −10.9% | 0.45% | $996.2M | −$122.3M | ||||||||
| Citigroup IncCOM · shares +1.4% · price −27.4% | 0.41% | $905.5M | −$337.7M | ||||||||
| Cvs Health CorpCOM · shares +28% · price −16.8% | 0.41% | $903.6M | −$141.9M | ||||||||
| Medtronic PlcCLA · shares +0.4% · price −7.5% | 0.36% | $793.4M | −$64.4M | ||||||||
| Simon Ppty Group Inc NewCOM · shares +0.5% · price −5.0% | 0.35% | $780.8M | −$40.5M | ||||||||
| Anthem IncCOM · shares +0.4% · price −4.2% | 0.35% | $776.2M | −$33.6M | ||||||||
| Unitedhealth Group IncCOM · shares −2.9% · price −6.4% | 0.35% | $763.4M | −$51.8M | ||||||||
| MetaCLA · shares +8.8% · price −20.3% | 0.34% | $746.3M | −$174.7M | ||||||||
| Total · 3,448 positions | 100% | $220.75B | −$42.17B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 3,335 stocks held throughout, down $42.17B (−16.7%).
- American Tower+$82.7M+9%
- Esterline Technologies Corp+$71.8M+34%
- Procter And Gamble Co+$58.1M+10%
- Belmond Ltd+$55.1M+37%
- Anglogold Ashanti Ltd+$50.7M+46%
- Citigroup Inc−$337.7M−27%
- AT&T−$393.5M−15%
- Exxon Mobil Corp−$539.9M−20%
- Amazon−$606.5M−25%
- Apple−$1.11B−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 12 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | $551.84B+15% | SEC ↗ |
| Q1 2026 | May 7, 2026 | $481.39B+1% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $476.72B+2% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $466.01B+8% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $431.92B+7% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $402.31B−3% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $416.38B+1% | SEC ↗ |
| Q3 2024 | Nov 7, 2024 | $412.28B+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $382.85B+4% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $369.36B+8% | SEC ↗ |
| Q4 2023 | Feb 7, 2024 | $342.47B+12% | SEC ↗ |
| Q3 2023 | Nov 9, 2023 | $304.90B−3% | SEC ↗ |
| Q2 2023 | Aug 9, 2023 | $313.77B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $296.87B−12% | SEC ↗ |
| Q4 2022 | Feb 9, 2023 | $338.47B+30% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $260.47B−7% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $278.78B−14% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $324.62B−2% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $330.75B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $310.45B−2% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $315.84B+4% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $302.34B+9% | SEC ↗ |
| Q4 2020 | Mar 8, 2021 (amended) | $276.93B+17% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $235.82B+4% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $227.51B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $191.95B−30% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $274.39B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $257.34B−0% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $257.55B+3% | SEC ↗ |
| Q1 2019 | Aug 12, 2019 (amended) | $251.08B+14% | SEC ↗ |
| Q4 2018 | Feb 26, 2019 (amended) | $220.75B−16% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $262.71B+5% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $250.84B+5% | SEC ↗ |
| Q1 2018 | May 11, 2018 | $239.94B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $241.23B+5% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $228.83B+6% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $216.59B+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $209.23B+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $200.21B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $185.01B+6% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $173.79B+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $167.06B | SEC ↗ |